BDUUF (Bangkok Dusit Medical Services PCL) Growth Rank: 10 (As of Sep. 12, 2026) — 11% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDUUF Bangkok Dusit Medical Services PCL BDUUF
94 GF Score
Price $0.64
GF Value $0.79
! 2 Warning Signs
View Full Analysis

What is Bangkok Dusit Medical Services PCL Growth Rank?

Bangkok Dusit Medical Services PCL BDUUF 94 Growth Rank is 10 as of Sep. 12, 2026, which is 11% above its 10-year median of 9.00. GuruFocus rates BDUUF with a GF Score™ of 94/100 and a GF Value™ of $0.79. The stock has 2 warning signs investors should review.

Bangkok Dusit Medical Services PCL has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Bangkok Dusit Medical Services PCL Growth Rank Related Terms

BDUUF vs HCA, THC, EHC: Growth Rank Comparison

For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bangkok Dusit Medical Services PCL Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's Growth Rank distribution charts can be found below:

* The bar in red indicates where Bangkok Dusit Medical Services PCL's Growth Rank falls into.


BDUUF
94GF Score
Bangkok Dusit Medical Services PCL BDUUF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Bangkok Dusit Medical Services PCL (BDUUF) has a Growth Rank of 10 as of Sep. 12, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Bangkok Dusit Medical Services PCL and its competitors. This is 11% above median its historical median of 9.00. Over the past decade, Bangkok Dusit Medical Services PCL's Growth Rank has ranged from 3.00 to 10.00.
Is Bangkok Dusit Medical Services PCL's Growth Rank too high?
Bangkok Dusit Medical Services PCL's current Growth Rank of 10 is 11% above median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's Growth Rank compare to HCA and THC?
Bangkok Dusit Medical Services PCL's Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, Bangkok Dusit Medical Services PCL's own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Bangkok Dusit Medical Services PCL and its competitors. Bangkok Dusit Medical Services PCL's current Growth Rank is 10, which is 11% above median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Bangkok Dusit Medical Services PCL (BDUUF) has a current Growth Rank of 10. The stock's GF Value™ is $0.79, compared to a current price of $0.64 — trading 18.6% below its estimated fair value. The current Growth Rank is 10, which is 11% above median its 10-year median of 9.00. Bangkok Dusit Medical Services PCL's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDUUF), the current Growth Rank is 10 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bangkok Dusit Medical Services PCL (BDUUF) Overvalued in 2026?

Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued. The current stock price of $0.64 is trading 18.6% below its estimated GF Value™ of $0.79.

Key valuation signals for BDUUF:

  • Growth Rank: 10 (11% above median its 10-year median of 9.00)
  • GF Value™: $0.79 vs. price of $0.64 (18.6% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the BDUUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bangkok Dusit Medical Services PCL Business Description

Address New Petchburi Road, 2, Soi Soonvijai 7, Bang Kapi, Huaykwang, Bangkok, THA, 10310
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
94GF Score

Get the complete analysis for BDUUF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price
$0.79
GF Value